Analyst Ratings for AbCellera Biologics (ABCL)
ABCL Rating Summary
ABCL Price Target Summary
- Highest: $13.00 (Jones Trading)
- Lowest: $4.00 (Leerink)
- Average: $9.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.60 (+67.8%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
Avg. $ Target:
$9.60 (+67.8%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/5/2026 | Cantor Fitzgerald » Updated 5/12/2026 |
Steve Seedhouse | New Coverage | Overweight (N/A) |
11.00 (7.00) |
4.59 (5.72) |
24.62% | Details |
| 4/9/2026 | Jones Trading » Updated 5/12/2026 |
Debanjana Chatterjee | New Coverage | Buy (N/A) |
13.00 (11.00) |
3.43 (5.72) |
66.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
